EP. 1: The Multidisciplinary Theme of CMSC 2020
EP. 2: Progressive MS: The 2020 Whitaker Lecture
EP. 3: Ocrelizumab Compared to Glatiramer Acetate and Dimethyl Fumarate for MS
EP. 4: Post Hoc Analysis: Phase 3 ASCLEPIOS I and II Trials in Relapsing MS
EP. 5: Primary Results From the ENSEMBLE PLUS Study
EP. 6: Post Hoc Analysis: Phase 3 EXPAND Trial in Secondary Progressive MS
EP. 7: Open-Label Extension: Phase 3 OPERA I and II Trials in Relapsing MS
EP. 8: CMSC Data Release: Abstract DXT58 and MS Risk Reduction
EP. 9: Open-Label Extension: BTKI in Relapsing MS Over 108 Weeks
